Repository logo
 

EARLY LIFE STRESS AND PHARMACEUTICAL POLLUTANTS: DEVELOPMENTAL TOXICITY OF EMERGING AQUATIC CONTAMINANTS IN A MODEL TERRESTRIAL SPECIES

dc.access.optionRestricted Campus Access Only
dc.contributor.advisorDeWitt, Jamie C.
dc.contributor.authorMeadows, Jacqueline Ruth
dc.contributor.departmentPharmacology and Toxicology
dc.date.accessioned2019-08-21T18:38:10Z
dc.date.available2021-08-01T08:01:55Z
dc.date.created2019-08
dc.date.issued2019-07-18
dc.date.submittedAugust 2019
dc.date.updated2019-08-19T17:36:27Z
dc.degree.departmentPharmacology and Toxicology
dc.degree.disciplinePHD-Pharmacology - Toxicology
dc.degree.grantorEast Carolina University
dc.degree.levelDoctoral
dc.degree.namePh.D.
dc.description.abstractTrace amounts of pharmaceutical and personal care products are plaguing water sources around the globe, and with no current regulations, these emerging contaminants pose a threat to environmental and human health. While there are dozens of studies describing the toxicity of pharmaceutical pollutants in aquatic organisms, virtually no studies exist pertaining to the potential impacts of environmentally relevant concentrations of these biologically active compounds on terrestrial beings. Further, even less is known about the potential hazards to susceptible populations and the long-lasting effects of chronic exposure. In this dissertation, we investigated the effects of developmental exposure to three abundantly detected pharmaceuticals, fluoxetine, fenofibrate, and norethisterone, in an in ovo chicken model, a well-accepted model of developmental ecotoxicity. Following developmental exposure, general biomarkers of toxicity were evaluated in addition to biomarkers associated specifically with the stress axis. We hypothesized that the developmental stress axis, a highly conserved system among vertebrate species, would serve as a sensitive axis that can be altered by pharmaceutical pollutant exposure. Indeed, in one day old chicken hatchlings, we detected alterations within the stress axis, particularly in DNA methylation alterations. In subsequent studies, we observed persistent molecular changes within the stress axis, including lowered basal corticosterone levels, reduced glucocorticoid receptor content, and insufficient immune responses in developmentally exposed chickens raised to two weeks old. Additionally, we suggest key components of an adverse outcome pathway that could help describe the toxicity of pharmaceutical pollutants in a non-aquatic species. Together, these experiments demonstrate, for the first time, the toxicity of environmental concentrations of pharmaceutical pollutants in a sentinel terrestrial species.
dc.embargo.lift2021-08-01
dc.format.mimetypeapplication/pdf
dc.identifier.urihttp://hdl.handle.net/10342/7440
dc.language.isoen
dc.publisherEast Carolina University
dc.subjectPharmaceutical Pollutants
dc.subjectFluoxetine
dc.subjectEarly Life Stress
dc.subjectHPA Axis
dc.subject.meshPharmaceutical Preparations
dc.subject.meshEnvironmental Pollutants
dc.subject.meshI-antigen
dc.subject.meshHospitals
dc.subject.meshStress, Psychological
dc.subject.meshDrug Development
dc.titleEARLY LIFE STRESS AND PHARMACEUTICAL POLLUTANTS: DEVELOPMENTAL TOXICITY OF EMERGING AQUATIC CONTAMINANTS IN A MODEL TERRESTRIAL SPECIES
dc.typeDoctoral Dissertation
dc.type.materialtext

Files